Abbott Laboratories ABT

Lisa D. Earnhardt, 2023 to present- Executive Vice President and Group President, Medical Devices. 2019 to 2023- Executive Vice President, Medical Devices. Elected Corporate Officer- 2019.

Mr. Christopher J. Scoggins, 2025 to present- Executive Vice President, Diabetes Care. 2023 to 2024- Senior Vice President, Commercial Operations and Marketing, Abbott Diabetes Care. 2021 to 2023- Vice President, Commercial Operations and Marketing, Abbott Diabetes Care. 2019 to 2021- Senior Vice President, Rapid Diagnostics. Elected Corporate Officer- 2015.

Daniel Salvadori, 2021 to present- Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products. 2017 to 2021- Executive Vice President, Nutritional Products. Elected Corporate Officer- 2014.

Ms. McKinstry, Lead Independent Director. Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., a global information, software, and services provider, from September 2003 to February 2026, and a member of its Executive Board from June 2001 to February 2026. Member of the J.P. Morgan International Council. Serves on the Board of Directors of Russell Reynolds Associates and the Board of Overseers of Columbia Business School. Other public company boards: Accenture plc, Mondelez International, Inc.

Mr. Stratton, Independent Director. Professional Background: Executive Chairman of Frontier Communications Parent, Inc., a telecommunications company, since April 2021; Executive Vice President and President of Global Operations of Verizon Communications Inc. from 2015 to 2018; Executive Vice President and President of Global Enterprise and Consumer Wireline of Verizon from 2014 to 2015; President of Verizon Enterprise Solutions from 2012 to 2014; Chief Operating Officer and Executive Vice President of Verizon Wireless from 2010 to 2012; Member of The President's National Security Telecommunications Advisory Committee from 2012 to 2018; Director of the Cellular Telecommunications Industry Association from 2015 to 2018. Other Public Company Boards: General Dynamics Corporation.

Dr. Sally E. Blount, President and Chief Executive Officer of Catholic Charities of the Archdiocese of Chicago since August 2020; Michael L. Nemmers Professor of Strategy at the J.L. Kellogg Graduate School of Management at Northwestern University since 2010; Dean of the J.L. Kellogg Graduate School of Management at Northwestern University from 2010 to 2018; Dean of the New York University Undergraduate College and Vice Dean of its Leonard N. Stern School of Business from 2004 to 2010; Professor at the New York University Leonard School of Business from 2001 to 2010, and became the Abraham L. Gitlow Professor of Management in 2004; Held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001; Served on the Board of Directors of Ulta Beauty, Inc. from 2017 to 2022, the Board of Directors of the Economic Club of Chicago from 2017 to 2023, and the Board of Directors of the Joyce Foundation from 2017 through 2025.

Ms. Claire Babineaux-Fontenot, Chief Executive Officer of Feeding America, a U.S. hunger-relief charitable organization, since 2018; Founder of CBF Consulting Group, LLC, a business consulting firm, since 2017; Executive Vice President and Global Treasurer of Walmart Inc., a multinational retail corporation operating supercenters, discount department stores, and eCommerce websites, from 2014 to 2017; Senior Vice President and Chief Tax Officer of Walmart, from 2007 to 2014; Vice President of Audits and Tax Policy of Walmart, from 2004 to 2007; Serves on the Board of Directors of New York Life Insurance Company and served on the Board of Directors of Charah Solutions, Inc. from 2018 to 2019.

Mr. Starks, Independent Director. Professional Background: Executive Chairman of the Board of St. Jude Medical, Inc., a medical device manufacturer, from January 2016 to January 2017, when Abbott completed its acquisition of St. Jude Medical; Chairman, President and Chief Executive Officer of St. Jude Medical from 2004 until his retirement in January 2016; President and Chief Operating Officer of St. Jude Medical from 2001 to 2004; President and CEO, Cardiac Rhythm Management Business of St. Jude Medical from 1997 to 2001.

Mr. Roman, Executive Chairman of the Board of 3M Company, a global manufacturing and technology company, from May 2024 to March 2025; Chairman of the Board, President and Chief Executive Officer of 3M from May 2019 to April 2024; Chief Executive Officer of 3M from July 2018 to May 2019; Chief Operating Officer and Executive Vice President of 3M from July 2017 to June 2018 with direct responsibilities for 3M's five business groups and its international operations; Executive Vice President, Industrial Business Group of 3M from June 2014 to July 2017; Senior Vice President, Business Development of 3M from May 2013 to June 2014; Vice President and General Manager of Industrial Adhesives and Tapes Division of 3M from September 2011 to May 2013. Other public company boards: Waystar Holding Corp.

Ms. Michelle A. Kumbier, Independent Director. Professional Background: Senior Vice President and President, Turf & Consumer Products of Briggs & Stratton, LLC, a manufacturer and marketer of engines, batteries, and outdoor power equipment, since March 2022; Senior Vice President and Chief Operating Officer of Harley-Davidson Motor Company, a motorcycle and related products manufacturer, from 2017 to 2020; Senior Vice President of Motor Company Product and Operations of Harley-Davidson from 2015 to 2017; Held various other executive roles across Harley-Davidson, from 1997 to 2015; Held various positions at Kohler Company, maker of premium plumbing products, from 1986 to 1997. Served on the Board of Directors of Tenneco Inc. from 2021 to 2022. Other Public Company Boards: Teledyne Technologies Incorporated, Ryerson Holding Corporation.

Ms. Patricia P. Gonzalez, Vice President, Global FP&A of The Clorox Company, a manufacturer and marketer of consumer and professional products, since June 2023; Vice President and Treasurer of Clorox, responsible for treasury, investor relations, and real estate, from 2018 to 2023; Vice President of Finance, Household and Lifestyle Segments of Clorox from 2010 to 2017; Vice President of Finance, Global Strategic Initiatives of Clorox from 2008 to 2010; Held various leadership roles in finance across Clorox since joining Clorox in 1997; Prior to Clorox, worked in finance for American Airlines in Latin America.

Mr. Michael G. O'Grady Chairman of Northern Trust Corporation, a financial services company, since 2019, Chief Executive Officer since 2018, and President since 2017; President, Corporate & Institutional Services of Northern Trust from 2014 to 2016; Chief Financial Officer of Northern Trust from 2011 to 2014; Managing Director, Investment Banking Group of Bank of America Merrill Lynch from 2000 to 2011. Other Public Company Boards: Northern Trust Corporation.

General McDew, Four-star general who served for 36 years in the United States military before retiring in October 2018; Commander, U.S. Transportation Command, the single manager for global air, land and sea transportation for the U.S. Department of Defense from 2015 to 2018; Held various leadership roles across the U.S. Military, including Vice Director for Strategic Plans and Policy for the Joint Chiefs of Staff, Military Aide to the President, Director of Air Force Public Affairs, and Chief of Air Force Senate Liaison Division; Serves on the Board of Directors of United Services Automobile Association, Boys & Girls Club of America, and Manns Home Youth Foundation. Other Public Company Boards: Parsons Corporation and General Electric Company.

Nita Ahuja, M.D. Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, Professor in the Department of Surgery, and alternating Chair or Vice Chair of the Board of the University of Wisconsin Hospitals and Clinics Authority since May 2025. Chair of the Department of Surgery at Yale School of Medicine from 2018 to 2025, Surgeon-in-Chief for Yale New Haven Health System and Board member of Yale New Haven Hospital from 2020 to 2025, Chair of the Yale Medicine Faculty Practice Plan from 2020 to 2024, and Interim Chief of the Yale Cancer Center from 2021 to 2022. Vice Chair of Academic Affairs, Department of Surgery at the Johns Hopkins University School of Medicine from 2014 to 2018, and Chief, Division of Surgical Oncology at The Johns Hopkins Hospital from 2016 to 2018. Serves as an elected member of the National Academy of Medicine and on the Board of Directors of the Association of American Medical Colleges, and has served as an elected national representative to the Commission on Cancer for the American College of Surgeons.

Mr. Eric Shroff, 2025 to present- Senior Vice President, Rapid and Molecular Diagnostics. 2018 to 2025- Vice President, Abbott Point of Care. Elected Corporate Officer- 2018.

Louis H. Morrone, 2023 to present- Executive Vice President, Core Diagnostics. 2021 to 2023- Senior Vice President, Rapid Diagnostics. 2017 to 2021- Vice President, Transfusion Medicine. Elected Corporate Officer- 2017.

Mary K. Moreland, 2019 to present- Executive Vice President, Human Resources. Elected Corporate Officer- 2019.

John A. McCoy, Jr., 2023 to present- Vice President, Finance and Controller. 2021 to 2023- Vice President, Treasurer. 2018 to 2021- Divisional Vice President, Controller, Rapid Diagnostics. Elected Corporate Officer- 2021.

Ms. Elizabeth C. Cushman, 2025 to present- Executive Vice President, General Counsel and Secretary. She was appointed to this role in June 2025. 2024 to 2025- Senior Vice President, Legal. 2023 to 2024- Vice President, Specialty Legal. 2021 to 2023- Divisional Vice President and Associate General Counsel, Legal Regulatory and Compliance.